These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 11274622

  • 1. Paroxetine for the prevention of depression induced by high-dose interferon alfa.
    Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH.
    N Engl J Med; 2001 Mar 29; 344(13):961-6. PubMed ID: 11274622
    [Abstract] [Full Text] [Related]

  • 2. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
    Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH.
    Biol Psychiatry; 2003 Nov 01; 54(9):906-14. PubMed ID: 14573318
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine for the prevention of depression induced by interferon alfa.
    Kraus MR, Schäfer A, Scheurlen M.
    N Engl J Med; 2001 Aug 02; 345(5):375-6. PubMed ID: 11484704
    [No Abstract] [Full Text] [Related]

  • 4. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
    Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH.
    Neuropsychopharmacology; 2002 May 02; 26(5):643-52. PubMed ID: 11927189
    [Abstract] [Full Text] [Related]

  • 5. Retinopathy associated with high-dose interferon alfa-2b therapy.
    Hejny C, Sternberg P, Lawson DH, Greiner K, Aaberg TM.
    Am J Ophthalmol; 2001 Jun 02; 131(6):782-7. PubMed ID: 11384576
    [Abstract] [Full Text] [Related]

  • 6. Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
    McNutt MD, Liu S, Manatunga A, Royster EB, Raison CL, Woolwine BJ, Demetrashvili MF, Miller AH, Musselman DL.
    Neuropsychopharmacology; 2012 May 02; 37(6):1444-54. PubMed ID: 22353759
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
    Morasco BJ, Rifai MA, Loftis JM, Indest DW, Moles JK, Hauser P.
    J Affect Disord; 2007 Nov 02; 103(1-3):83-90. PubMed ID: 17292481
    [Abstract] [Full Text] [Related]

  • 8. Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.
    Sarkar S, Schaefer M.
    Psychosomatics; 2014 Nov 02; 55(3):221-34. PubMed ID: 24012293
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
    Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.
    Aliment Pharmacol Ther; 2002 Jun 02; 16(6):1091-9. PubMed ID: 12030950
    [Abstract] [Full Text] [Related]

  • 10. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.
    CNS Drugs; 2002 Jun 02; 16(6):425-34. PubMed ID: 12027788
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of mirtazapine as add-on to paroxetine v. paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine: a two-phase, multicentre, randomized, double-blind clinical trial.
    Xiao L, Zhu X, Gillespie A, Feng Y, Zhou J, Chen X, Gao Y, Wang X, Ma X, Gao C, Xie Y, Pan X, Bai Y, Xu X, Wang G, Chen R.
    Psychol Med; 2021 May 02; 51(7):1166-1174. PubMed ID: 31931894
    [Abstract] [Full Text] [Related]

  • 12. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS, Noble S, Benfield P.
    Drugs; 1998 Jan 02; 55(1):85-120. PubMed ID: 9463792
    [Abstract] [Full Text] [Related]

  • 13. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.
    JAMA; 1998 Jan 28; 279(4):287-91. PubMed ID: 9450712
    [Abstract] [Full Text] [Related]

  • 14. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
    Kraus MR, Schäfer A, Schöttker K, Keicher C, Weissbrich B, Hofbauer I, Scheurlen M.
    Gut; 2008 Apr 28; 57(4):531-6. PubMed ID: 18079286
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice.
    Freed E, Goldney R, Lambert T, Tiller J, Johnston R.
    Aust N Z J Psychiatry; 1999 Jun 28; 33(3):416-21. PubMed ID: 10442799
    [Abstract] [Full Text] [Related]

  • 16. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RM, Ascher JA.
    J Clin Psychiatry; 2000 Mar 28; 61(3):196-202. PubMed ID: 10817105
    [Abstract] [Full Text] [Related]

  • 17. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
    Raison CL, Woolwine BJ, Demetrashvili MF, Borisov AS, Weinreib R, Staab JP, Zajecka JM, Bruno CJ, Henderson MA, Reinus JF, Evans DL, Asnis GM, Miller AH.
    Aliment Pharmacol Ther; 2007 May 15; 25(10):1163-74. PubMed ID: 17451562
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T, Ikeda A, Ueki M.
    J Med; 2004 May 15; 35(1-6):151-62. PubMed ID: 18084873
    [Abstract] [Full Text] [Related]

  • 19. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.
    J Affect Disord; 2000 Aug 15; 59(2):119-26. PubMed ID: 10837880
    [Abstract] [Full Text] [Related]

  • 20. Sertraline treatment of interferon-alfa-induced depressive disorder.
    Schramm TM, Lawford BR, Macdonald GA, Cooksley WG.
    Med J Aust; 2000 Oct 02; 173(7):359-61. PubMed ID: 11062791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.